Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Debt to Equity (2020 - 2022)

Historic Debt to Equity for Ensysce Biosciences (ENSC) over the last 3 years, with Q4 2022 value amounting to -$0.03.

  • Ensysce Biosciences' Debt to Equity rose 9361.1% to -$0.03 in Q4 2022 from the same period last year, while for Dec 2022 it was -$0.03, marking a year-over-year increase of 9361.1%. This contributed to the annual value of -$0.03 for FY2022, which is 9361.1% up from last year.
  • Latest data reveals that Ensysce Biosciences reported Debt to Equity of -$0.03 as of Q4 2022, which was up 9361.1% from -$0.34 recorded in Q3 2022.
  • Over the past 5 years, Ensysce Biosciences' Debt to Equity peaked at $1.14 during Q1 2022, and registered a low of -$5.49 during Q3 2021.
  • In the last 3 years, Ensysce Biosciences' Debt to Equity had a median value of -$0.03 in 2022 and averaged -$0.6.
  • Per our database at Business Quant, Ensysce Biosciences' Debt to Equity tumbled by 494575.86% in 2021 and then soared by 9371.56% in 2022.
  • Over the past 3 years, Ensysce Biosciences' Debt to Equity (Quarter) stood at $0.11 in 2020, then tumbled by 580.66% to -$0.54 in 2021, then soared by 93.61% to -$0.03 in 2022.
  • Its last three reported values are -$0.03 in Q4 2022, -$0.34 for Q3 2022, and -$0.45 during Q2 2022.